Bialaphos: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 31: | Line 31: | ||
{{Antibiotics-stub}} | {{Antibiotics-stub}} | ||
{{medicine-stub}} | {{medicine-stub}} | ||
== Bialaphos == | |||
<gallery> | |||
File:Bialaphos.svg|Bialaphos | |||
</gallery> | |||
Latest revision as of 21:06, 25 February 2025
Bialaphos is a tripeptide antibiotic that is produced by several species of Streptomyces. It is a potent inhibitor of glutamine synthetase, an enzyme that plays a crucial role in the nitrogen cycle of plants and bacteria.
History[edit]
Bialaphos was first isolated in the 1970s from the soil bacterium Streptomyces hygroscopicus. The discovery of bialaphos and its unique mode of action led to the development of glufosinate, a broad-spectrum herbicide that is widely used in agriculture.
Structure and Biosynthesis[edit]
Bialaphos is a tripeptide composed of alanine, theanine, and phosphinothricin. The biosynthesis of bialaphos involves several enzymes, including nonribosomal peptide synthetases and phosphinothricin tripeptide synthetase.
Mode of Action[edit]
Bialaphos inhibits glutamine synthetase, an enzyme that catalyzes the conversion of glutamate and ammonia into glutamine. This inhibition disrupts the nitrogen cycle, leading to the death of the organism.
Uses[edit]
Bialaphos is used as a selective agent in the production of genetically modified crops that are resistant to glufosinate. It is also used in research to study the function of glutamine synthetase and the nitrogen cycle.
See Also[edit]
| This article is a stub. You can help WikiMD by registering to expand it. |
Bialaphos[edit]
-
Bialaphos
